This downloadable slideset reviews new, clinically relevant HIV data, with emphasis on PrEP outcomes, ART efficacy in first-line and switch settings, metabolic and weight considerations with HIV therapy, and regimen selection during pregnancy.
Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provide insights on the most clinically relevant new HIV data presented at 3 recent conferences, including data on HIV prevention, first-line and switch strategies, and weight gain during ART.
Earlier this year, the US government released a plan, with PrEP among its foundational pillars, to substantially reduce new HIV infections. Here’s my take on how data from IDWeek 2019 appraise progress toward this goal.
EACS 2019 delivered a wealth of new data applicable to women with HIV. Why is this so important? Here’s my take.
Chloe Orkin, MBChB, FRCP, MD, and Jürgen K. Rockstroh, MD, review new prevention, treatment, and outcome data from the 2019 IDWeek and EACS meetings that will affect practice for European clinicians managing HIV patient care.
Download slides with expert perspective on how data from Fall 2019 HIV conferences affect the prevention and treatment of HIV in Europe.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.